Feasibility Study of the Intravascular Ventricular Assist System (iVAS)

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT02645539

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
NuPulseCV (from the registry)
Registry
  • NCT NCT02645539
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02645539. Allocation not applicable; no masking; primary purpose treatment. Start 2016-04 (actual); primary completion 2020-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Feasibility Study of the Intravascular Ventricular Assist System (iVAS)
Condition
Heart Failure NYHA Class III
Condition
Heart Failure NYHA Class IV
Intervention (Device)
intravascular ventricular assist system (iVAS)
Lead sponsor
NuPulseCV (class: industry)

Record details

Record id
cardio:ct-nct02645539
Content hash
bfea46eb10fcb709e0a7a1c9a62330c2b69efbe9d27ed695799e12540b5c1096